Blog
RSS FeedPosted by Michael Wonder on 03 Oct 2016
NICE says no to daclizumab (Zinbryta)
3 October 2016 - The MS Trust is disappointed that NICE does not intend to recommend that daclizumab (Zinbryta) be made ...
Posted by Michael Wonder on 27 Sep 2016
Zinbryta approved by TGA
27 September 2016 - The TGA has approved Biogen's Zinbryta. ...
Posted by Michael Wonder on 17 Sep 2016
ICER announces updates to timeline for review of therapies for multiple sclerosis
16 September 2016 - The ICER has updated the timeline of its review of disease-modifying therapies for patients with multiple sclerosis. ...
Posted by Michael Wonder on 26 Aug 2016
New Brunswick includes Lemtrada (alemtuzumab) on provincial drug program for eligible patients
25 August 2016 - Unique treatment delivered in only two cycles one year apart. ...
Posted by Michael Wonder on 18 Jul 2016
ICER releases addendum to draft scoping document for MS review
18 July 2016 - The ICER has released an addendum to the draft scoping document on disease-modifying therapies for multiple sclerosis. ...
Posted by Michael Wonder on 18 Jul 2016
Merck receives European Medicines Agency acceptance for review of marketing authorization application for cladribine tablets
18 July 2016 - Merck today announced that the EMA has accepted for review the marketing authorisation application of the ...
Posted by Michael Wonder on 06 Jul 2016
Saskatchewan includes Lemtrada (alemtuzumab) on MS Drugs Program for eligible patients
5 July 2016 - Unique treatment delivered in only two cycles one year apart. ...
Posted by Michael Wonder on 05 Jul 2016
Biogen and AbbVie’s once-monthly Zinbryta (daclizumab) approved in European Union for treatment of multiple sclerosis
5 July 2016 - Zinbryta significantly reduced multiple measures of disease activity in patients with relapsing forms of multiple sclerosis. ...
Posted by Michael Wonder on 28 May 2016
FDA approves Zinbryta to treat multiple sclerosis
27 May 2016 - The U.S. FDA today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple ...
Posted by Michael Wonder on 09 Dec 2015
New treatment options for patients with multiple sclerosis
9 December 2015 - Funding for two new medicines will provide patients with more convenient options for treating multiple sclerosis. ...
Posted by Michael Wonder on 05 Dec 2015
PHARMAC decisions relating to new multiple sclerosis treatments
4 December 2015 - PHARMAC is pleased to announce the approval of proposals to fund two new treatments for Multiple Sclerosis ...
Posted by Michael Wonder on 11 Sep 2015
Merck intends to submit cladribine tablets to treat multiple sclerosis for registration in Europe
11 September 2015 -Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials ...